Hamble Healthcare Ltd 14879859 false 2023-05-19 2024-08-31 2024-08-31 The principal activity of the company is that of a residential and nursing care home. Digita Accounts Production Advanced 6.30.9574.0 true true 14879859 2023-05-19 2024-08-31 14879859 2024-08-31 14879859 bus:Consolidated 2024-08-31 14879859 core:RetainedEarningsAccumulatedLosses 2024-08-31 14879859 core:ShareCapital 2024-08-31 14879859 core:CurrentFinancialInstruments 2024-08-31 14879859 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 14879859 core:Non-currentFinancialInstruments core:AfterOneYear 2024-08-31 14879859 bus:SmallEntities 2023-05-19 2024-08-31 14879859 bus:Audited 2023-05-19 2024-08-31 14879859 bus:FilletedAccounts 2023-05-19 2024-08-31 14879859 bus:SmallCompaniesRegimeForAccounts 2023-05-19 2024-08-31 14879859 bus:RegisteredOffice 2023-05-19 2024-08-31 14879859 bus:Director1 2023-05-19 2024-08-31 14879859 bus:Director2 2023-05-19 2024-08-31 14879859 bus:Director3 2023-05-19 2024-08-31 14879859 bus:Director4 2023-05-19 2024-08-31 14879859 bus:PrivateLimitedCompanyLtd 2023-05-19 2024-08-31 14879859 core:FurnitureFittingsToolsEquipment 2023-05-19 2024-08-31 14879859 core:LandBuildings 2023-05-19 2024-08-31 14879859 core:OtherPropertyPlantEquipment 2023-05-19 2024-08-31 14879859 1 2023-05-19 2024-08-31 14879859 countries:EnglandWales 2023-05-19 2024-08-31 iso4217:GBP xbrli:pure

Registration number: 14879859

Prepared for the registrar

Hamble Healthcare Ltd

Annual Report and Financial Statements

for the Period from 19 May 2023 to 31 August 2024

 

Hamble Healthcare Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 6

 

Hamble Healthcare Ltd

Company Information

Directors

Y Somji

M R P Visram

N M Visram

S Visram

Registered office

Waterside House
Abbey Hill
Netley Abbey
Southampton
SO31 5FA

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Hamble Healthcare Ltd

(Registration number: 14879859)
Balance Sheet as at 31 August 2024

Note

2024
£

Fixed assets

 

Tangible assets

4

5,194,575

Current assets

 

Debtors

5

81,167

Cash at bank and in hand

 

38,755

 

119,922

Creditors: Amounts falling due within one year

6

(505,424)

Net current liabilities

 

(385,502)

Total assets less current liabilities

 

4,809,073

Creditors: Amounts falling due after more than one year

6

(5,051,723)

Net liabilities

 

(242,650)

Capital and reserves

 

Called up share capital

100

Retained earnings

(242,750)

Shareholders' deficit

 

(242,650)

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 16 May 2025 and signed on its behalf by:
 


N M Visram
Director

 

Hamble Healthcare Ltd

Notes to the Financial Statements for the Period from 19 May 2023 to 31 August 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Waterside House
Abbey Hill
Netley Abbey
Southampton
SO31 5FA

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Name of parent of group

These financial statements are consolidated in the financial statements of Visram Limited.

The financial statements of Visram Limited may be obtained from Companies House.

Disclosure of long or short period

The financial statements cover a period of 470 days. This is to bring the year end in line with that of the rest of the group

Going concern

Notwithstanding the net liability position shown on the balance sheet, the financial statements have been prepared on the going concern basis. The directors have considered the forecast cash flows and the cash requirements of the business in their assessment of going concern. As a result of this assessment it was concluded that the cash requirements of the business for the 12 months from signing will be met through a combination of operational cash flows and intergroup loans and thus the business is deemed to operate as a going concern.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

 

Hamble Healthcare Ltd

Notes to the Financial Statements for the Period from 19 May 2023 to 31 August 2024

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

No depreciation has been charged during the period whilst the asset is under construction.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Hamble Healthcare Ltd

Notes to the Financial Statements for the Period from 19 May 2023 to 31 August 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was as follows:

 

Hamble Healthcare Ltd

Notes to the Financial Statements for the Period from 19 May 2023 to 31 August 2024

 

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Assets under construction
 £

Total
£

Cost and carrying amount

Additions and at 31 August 2024

2,623,641

155,758

2,415,176

5,194,575

 

5

Debtors

Note

2024
£

Prepayments

 

713

Deferred tax asset

80,454

 

81,167

 

6

Creditors

2024
£

Due within one year

Bank borrowings

103,277

Trade creditors

395,907

Social security and other taxes

2,640

Accruals

3,600

505,424

Due after one year

Bank borrowings

2,396,723

Bank borrowings are repayable by monthly instalments with the final repayment date falling on September 2043. Interest is charged at the base rate plus 2.37% per annum. The bank loan is secured over the assets of the company.

 

7

Parent and ultimate parent undertaking

The company's immediate and ultimate parent undertaking is Visram Limited, incorporated in England and Wales.

The financial statements for Visram Limited are available upon request from Companies House.

 

8

Disclosure under Section 444(5B) CA 2006 relating to the independent auditor's report

As permitted by Section 444 CA 2006, these accounts do not contain a copy of the company’s Profit and Loss account or a copy of the Directors’ Report. Accordingly, the Independent Auditors’ Report has also been omitted.

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 16 May 2025 was Joanne Hartness, who signed for and on behalf of Hazlewoods LLP.